Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Vasc Surg. 2016 Apr 8;64(1):155–162. doi: 10.1016/j.jvs.2016.02.033

Table III.

Comparison of access outcomes and interventions in different groups.

Secondary access patency Access interventions per year
Comparison HR (95% CI) P-value Rate ratio P-value
All AVG vs all AVF 1.06 (0.83–1.35) .64 2.50 (2.22–2.78) <.0001
AVF-1 vs AVF-0 1.84 (1.30–2.60) < .0001 1.81 (1.49–2.20) < .0001
AVG-1 vs AVG-0 1.98 (1.52–4.02) < .0001 1.49 (1.27–1.74) < .0001
AVG-0 vs AVF-0 1.28 (0.91–1.78) .16 3.18 (2.70–3.76) < .0001
AVF-1 vs AVG-0 1.45 (1.08–2.01) .01 0.57 (0.49–0.66) < .0001

AVF-1, AVF with interventions prior to maturation

AVF-0, AVF without intervention prior to maturation

AVG-1, AVG with interventions prior to successful cannulation

AVG-0, AVG without interventions prior to successful cannulation

A HR or rate ratio >1 indicates that the first subgroup has a worse outcome than the second subgroup. A HR or rate ratio <1 indicates that that first subgroup has a better outcome than the second subgroup.